PhotoCure ASA - Annual General Meeting
The Annual General Meeting in PhotoCure ASA took place on 3 May 2005. The General Meeting approved the Directors' Report and the Annual Accounts, as well as the Board of Directors' proposed settlement of the deficit of 2004. Birgit Stattin Norinder was re-elected for another 2-year period as a member of the Board of Directors. In addition, Trine Bjøro was elected as a new director of the Board. The new Board of Directors of PhotoCure ASA consists of: Erik EngebretsenPer-Olof MårtenssonHalvor BjerkeTrine Bjøro Lars LindegrenBirgit Stattin Norinder The Nomination Committee was re-elected for a period of one year. The Nomination Committee consists of: Jónas EinarssonTharald BrøvigJohn Harald Henriksen In accordance with the proposals of the Board of Directors, the General Meeting also resolved to grant authority to the Board to increase the share capital.
PhotoCure ASA is a Norwegian pharmaceutical company founded in 1993 and listed on Oslo Stock Exchange. The company develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technologies, targeting key dermatology and oncology markets.
PhotoCure has two products with sales and marketing approvals: Metvix®, which is a product developed for the treatment of skin cancer (basal cell carcinoma) and pre-cancerous skin lesions (actinic keratosis), and Hexvix®, which is developed for the detection of bladder cancer. Both products are based on the same photodynamic technology, combining the drug known as a photosensitiser with a light source that activates the photosensitiser. PhotoCure is currently testing both products for new indications and aims to develop a pipeline of follow-on products and technologies.
PhotoCure, the PhotoCure logo, Metvix and Hexvix are trademarks or registered trademarks of PhotoCure ASA.
For further information, contact:
Kjetil Hestdal, President and CEO
E-mail: kh@photocure.no
Mobile: +47 913 19 535
Office: +47 22 06 22 10
Christian Fekete, CFO
E-mail: cf@photocure.no
Mobile: +47 916 42 938
Office: +47 22 06 22 10
www.photocure.com